Medications

Bamlanivimab plus etesevimab reduces SARS-CoV-2 viral load

(HealthDay)—Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in patients with mild-to-moderate ...

Diseases, Conditions, Syndromes

Do asymptomatic kids with COVID-19 carry less virus?

New questions are at the forefront as a study published in the Journal of Clinical Microbiology from nine children's hospitals finds that most asymptomatic children who tested positive for COVID-19 had relatively low levels ...

page 8 from 22